{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-033402","form_type":"8-K","ticker":"OPRX","cik":"0001448431","company_name":"OptimizeRx Corp","filed_at":"2025-04-18T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.324498+00:00","generated_at":"2026-05-23T10:57:24.594635+00:00","sec_items":["7.01","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"OptimizeRx plans new independent director in H2 2025; Whetstone withdraws nomination notice","bullets":["Plans to add a new independent director in H2 2025 as part of ongoing board refreshment.","Whetstone Capital Advisors withdrew its March 6 director nomination notice after constructive engagement.","Current board has five members; three new directors added since 2020 including Klema (2024) and Wasson (2020).","Chairperson Lynn Vos cites progress under CEO Steve Silvestro and commitment to recruiting qualified directors."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-033402","json":"https://secwatch.observer/filing/0001213900-25-033402.json","markdown":"https://secwatch.observer/filing/0001213900-25-033402.md","text":"https://secwatch.observer/filing/0001213900-25-033402.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1448431/000121390025033402/0001213900-25-033402-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1448431/000121390025033402/ea0238866-8k_optimize.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T10:57:24.594635+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}